Your browser doesn't support javascript.
loading
French general practitioners' and patients' acceptability of a public commitment charter and patient information leaflets targeting unnecessary antibiotic use: a qualitative study.
Essilini, Anaïs; Le Dref, Gaëlle; Bocquier, Aurélie; Kivits, Joëlle; Welter, Adeline; Pulcini, Céline; Thilly, Nathalie.
Afiliação
  • Essilini A; Université de Lorraine, APEMAC, F-54000, Nancy, France. anais.essilini@univ-lorraine.fr.
  • Le Dref G; Université de Lorraine, APEMAC, F-54000, Nancy, France.
  • Bocquier A; Université de Lorraine, APEMAC, F-54000, Nancy, France.
  • Kivits J; Université de Lorraine, APEMAC, F-54000, Nancy, France.
  • Welter A; Caisse Primaire d'Assurance Maladie du Bas Rhin, 67000, Strasbourg, France.
  • Pulcini C; Université de Lorraine, APEMAC, F-54000, Nancy, France.
  • Thilly N; Service de Maladies Infectieuses Et Tropicales, Université de Lorraine, CHRU-Nancy, 54000, Nancy, France.
Antimicrob Resist Infect Control ; 11(1): 32, 2022 02 08.
Article em En | MEDLINE | ID: mdl-35135624
ABSTRACT

BACKGROUND:

The 'AntibioCharte' randomised controlled study aimed at assessing the impact of a multifaceted antibiotic stewardship intervention targeting French general practitioners with higher-than-average antibiotic use. The intervention included a public commitment charter signed by the general practitioner, a non-prescription pad, and a patient information leaflet.

OBJECTIVES:

We conducted a qualitative study to evaluate general practitioners' fidelity in the intervention and its acceptability by patients and general practitioners.

METHODS:

This investigation was performed in northeastern France from July 2019 to May 2020, among the AntibioCharte intervention group after a 1-year implementation period. General practitioners' fidelity in the charter was assessed by direct observations; general practitioners' fidelity in the other tools, and acceptability of both general practitioners and patients were assessed through semi-structured face-to-face individual interviews.

RESULTS:

Twenty-seven general practitioners and 14 patients participated. General practitioners' fidelity varied according to the tool the charter was clearly displayed in most waiting rooms; the non-prescription pad was used throughout the intervention period by most general practitioners while the leaflet was used by fewer general practitioners. Both general practitioners and patients found the charter's content and form relevant, but few general practitioners felt themselves publicly engaged. The waiting room may not be appropriate to display the charter as some general practitioners forgot it and patients did not always read the displayed documents. General practitioners appreciated the pad and found that it could help them change their practices. It was perceived as a good tool to educate patients and manage their expectations for antibiotics. Patients appreciated the pad too, especially information on the infections' symptoms and their duration. Still, some patients feared that it could encourage doctors not to prescribe antibiotics. Unlike general practitioners, who considered the leaflet redundant with the information given during the consultation, patients found it useful to raise awareness on antibiotics' specificities and risks, and remind them of good practices.

CONCLUSIONS:

The AntibioCharte intervention was overall well accepted by general practitioners and patients. The non-prescription pad was the best perceived tool. Trial registration number ClinicalTrials.gov NCT04562571.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clínicos Gerais / Gestão de Antimicrobianos Tipo de estudo: Clinical_trials / Qualitative_research Limite: Humans Idioma: En Revista: Antimicrob Resist Infect Control Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Clínicos Gerais / Gestão de Antimicrobianos Tipo de estudo: Clinical_trials / Qualitative_research Limite: Humans Idioma: En Revista: Antimicrob Resist Infect Control Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
...